Casi Pharmaceuticals Inc Expected To Post A Loss Of 62 Cents A Share: Earnings Preview

CASI Pharmaceuticals

12/11/2024 13:55

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show
a fall in quarterly revenue when it reports  results on November
14 for the period ending September 30 2024
    * The Beijing-based  company is expected to report a
48.4% decrease in revenue to $4.56 million from $8.84 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for CASI Pharmaceuticals Inc
is
for a loss of 62 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is 6.00​, above​ its last closing price
of $5.59. ​​​

This summary was machine generated November 12 at 13:54 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)